PARG1 Antikörper (AA 161-392)
Kurzübersicht für PARG1 Antikörper (AA 161-392) (ABIN7167952)
Target
Alle PARG1 (ARHGAP29) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 161-392
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Rho GTPase-activating protein 29 protein (161-392AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PARG1 (ARHGAP29) (rho GTPase Activating Protein 29 (ARHGAP29))
-
Andere Bezeichnung
- ARHGAP29
-
Hintergrund
-
Background: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Has strong activity toward RHOA, and weaker activity toward RAC1 and CDC42. May act as a specific effector of RAP2A to regulate Rho. In concert with RASIP1, suppresses RhoA signaling and dampens ROCK and MYH9 activities in endothelial cells and plays an essential role in blood vessel tubulogenesis.
Aliases: ARHGAP 29 antibody, Arhgap29 antibody, ARHGAP29 protein antibody, MGC166097 antibody, PARG 1 antibody, PARG1 antibody, PTPL1 associated RhoGAP 1 antibody, PTPL1-associated RhoGAP protein 1 antibody, RHG29_HUMAN antibody, Rho GTPase activating protein 29 antibody, Rho GTPase activating protein 29 isoform CRA_a antibody, Rho GTPase activating protein 29 isoform CRA_b antibody, Rho GTPase-activating protein 29 antibody, Rho-type GTPase-activating protein 29 antibody
-
UniProt
- Q52LW3
Target
-